Urinary tract infection and Concomitant disease progression
Summary:
Concomitant disease progression is found among people with Urinary tract infection, especially for people who are male, 60+ old.
The study analyzes which people have Concomitant disease progression with Urinary tract infection. It is created by eHealthMe based on reports of 20 people who have Urinary tract infection from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Urinary tract infection?
Urinary tract infection is found to be associated with 3,015 drugs and 3,956 conditions by eHealthMe. Check the latest studies of Urinary tract infection.
What is Concomitant disease progression?
Concomitant disease progression (progress in accompanying disease) is found to be associated with 372 drugs and 622 conditions by eHealthMe. Check the latest studies of Concomitant disease progression.
20 people who have Urinary Tract Infection and Concomitant Disease Progression are studied.

Gender of people who have Urinary Tract Infection and experienced Concomitant Disease Progression *:
- female: 30 %
- male: 70 %
Age of people who have Urinary Tract Infection and experienced Concomitant Disease Progression *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 30 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 70 %
Common co-existing conditions for these people *:
- Immunodeficiency Disorders: 12 people, 60.00%
- Birth Control: 6 people, 30.00%
- Heart Disease: 1 person, 5.00%
- Cardiac Failure: 1 person, 5.00%
Common drugs taken by these people *:
- Valcyte: 12 people, 60.00%
- Iron Dextran: 12 people, 60.00%
- Prograf: 12 people, 60.00%
- Nexium: 8 people, 40.00%
- Prednisone: 7 people, 35.00%
- Aviane-21: 6 people, 30.00%
- Azathioprine: 6 people, 30.00%
- Cipro: 6 people, 30.00%
- Imuran: 6 people, 30.00%
- Amoxicillin: 6 people, 30.00%
Common symptoms for these people *:
- Diarrhea: 18 people, 90.00%
- Gastric Antral Vascular Ectasia (blood vessels in the lining of the stomach become fragile and become prone to rupture and bleeding): 12 people, 60.00%
- Anaemia Postoperative: 12 people, 60.00%
- Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 12 people, 60.00%
- Nausea (feeling of having an urge to vomit): 6 people, 30.00%
- Gallstones (stone formation by bile component): 6 people, 30.00%
- Abdominal Pain: 6 people, 30.00%
- Nausea And Vomiting: 6 people, 30.00%
- Pancreatitis (inflammation of pancreas): 6 people, 30.00%
- Multi-Organ Failure (multisystem organ failure): 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Concomitant disease progression?
- Check whether Concomitant disease progression is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Urinary tract infection (281,658 reports)
- Concomitant disease progression (3,142 reports)
All the drugs that are associated with Concomitant disease progression:
- Concomitant disease progression (372 drugs)
All the conditions that are associated with Concomitant disease progression:
- Concomitant disease progression (622 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Concomitant disease progression and Urinary tract infection, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Trulance and Rinvoq - a second ago
- Prednisone vs. Ultram, side effect and effectiveness comparison - 10 seconds ago
- Drug interactions of Arava and Taltz - 13 seconds ago
- Drug interactions of Amlodipine Besylate and Clemastine Fumarate - 21 seconds ago
- Drug interactions of Amlodipine Besylate and Dronabinol - 22 seconds ago
- Could Ramipril cause Vasodilatation? - 23 seconds ago
- Drug interactions of Methylprednisolone Sodium Succinate and Urso 250 - 23 seconds ago
- Could Fluorouracil cause Diffuse Interstitial Lung Disease? - 26 seconds ago
- Could Reclast cause Joint Pain? - 26 seconds ago
- Psoriatic Arthropathy and Eye Swelling - 29 seconds ago